Shimadzu, a worldwide leading manufacturer of diagnostic imaging equipment, achieved the ‘Global General Radiography Product Line Strategy Leadership Award 2017’.
Today, many congenital heart defects can be diagnosed in the unborn child – and even treated in utero. Monique Haak (46), gynaecologist-perinatologist and fetal surgeon at Leids University Medical Center (LUMC) in Leiden, The Netherlands, is an expert in the diagnosis and surgery of fetal heart defects.
A team under the direction of chemist Prof. Dr Peter Comba is investigating radioactive metal complexes for use in the diagnosis and treatment of tumors.
Certain members of Generation Y, who grew up alongside enormous information technology (IT) advances, now occupy decision-making roles. Meanwhile, generation Z is emerging into the continuing IT revolution; the digital world surrounds us.
In the nineties Deep Blue, the famous chess computer, defeated Kasparow. Only a year ago Google’s Deepmind managed to master the ancient Chinese Go, known for its utmost complexity.
Digital pathology has been the next big thing for about a decade. Yet, today only a few pathology laboratories are fully equipped to digitise their workflow, mainly for legal or financial reasons.
A national pathology image exchange platform for The Netherlands is expected to be in place and operational within the next 12 months.
The European Diagnostic Manufacturers Association EDMA (*) presented 2014 market data, and some countries, such as Germany, also provide estimates for 2015, based on Q1 through Q3 2015.
Dr Massimo Calabrese, head of the Complex Operative Unit of Diagnostic Senology in Genoa’s San Martino Hospital, examines aspects of stereotactic breast biopsy procedures and workflow and the need for improvements in certain areas of breast diagnostics.
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal Inc. develops and provides point-of-care blood diagnostic systems for healthcare enterprises, including the epoc Blood Analysis System, a handheld, wireless testing solution.
People with the movement disorder Parkinson’s disease have a much higher risk of the skin cancer melanoma, and vice versa, a Mayo Clinic study finds. Yet the results of the study argue against the Parkinson's drug levodopa as the cause.
The ADVIA Centaur® High-Sensitivity Troponin I (TNIH) assay* is the latest addition to Siemens Healthineers’ comprehensive cardiac menu to assist clinicians with the diagnosis and treatment of chest pain patients. Designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma, high-sensitivity troponin plays a…
Breast implants may impede an electrocardiogram (ECG) and could result in a false heart attack diagnosis, according to research by the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC).
Ultrasound is often the first line of imaging used in the diagnostic pathway of a patient’s journey into hospital. Additionally, the increased prevalence of chronic conditions and changes in the demographics of the general population has led to an increased demand for ultrasound. Fast-growing advances in technology also shift ultrasound into a more prominent role in patient diagnosis and…
Language recognition on the smartphone, spam filters in the e-mail programme, personalised product recommendations by Amazon or Netflix – all share one feature: they are based on an algorithm that recognises patterns in a set of data. This artificial generation of knowledge is called machine learning.
SpeeDx Pty, Ltd. announced an agreement with Cepheid for distribution of its PlexPCRTM and ResistancePlusTM molecular diagnostic products in key markets throughout Europe. The agreement, covering Germany, France, Italy, and the UK, will increase coverage for the market-leading ResistancePlus MG test, the first CE-IVD test for Mycoplasma genitalium to combine detection with testing for…
Oxford Gene Technology (OGT), The Molecular Genetics Company, today announced that it has signed an agreement to be acquired by Sysmex Corporation, a Japanese in vitro diagnostic company.
In order to enhance its hematology portfolio for the small-mid size laboratories segment, HORIBA Medical has developed a new hematology diagnostic solution. The new Yumizen H550 has been designed to meet the challenging laboratories requirements of providing a cost effective solution based on ‘state of art’ hematology diagnosis combined with user friendly operation.
For almost three quarters of hepatocellular carcinoma (HCC) patients in Europe it is too late for curative treatment because the disease is often only diagnosed at a very advanced stage. Interviewed Professor Guido Gerken MD, Director of the Department for Gastroenterology and Hepatology at University Hospital Essen, about improved and timelier diagnostic capabilities that have already been…
The ‘Transmission, Prevention, and Reporting of Emerging Infectious Diseases’ program for the International Conference IMED 2016 in Vienna, this November, reflected events in the field of emerging diseases that have occurred over the last two years. Therefore, key congress topics included the Zika virus, the effects of global warming and the unusually high number of hospital-acquired…
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed an agreement with Thermo Fisher Scientific, the world leader in serving science. The announcement was made at the 27th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna to submit its ResistancePlus MG Test for the detection of Mycoplasma genitalium to the US Food & Drug…
European Hospital reports a new approach in molecular diagnostics introduced during the IASLC World Conference in Vienna.
Novel blood or urine tests can now detect a tumour and but might in future be able to say what type of cancer is developing in which organ.
Just in time for the ECR, Siemens Healthineers is coming up with an innovation. Magnetom Vida, the new high-end 3 Tesla MRI scanner with BioMatrix technology from Siemens Healthineers, was launched to the public at University Hospital Tübingen yesterday, where the first system is installed. The new BioMatrix technology adapts automatically to individual anatomical and physiological…
An international research team from the University Hospital of Munich (LMU), Newcastle University and the University of Liverpool has identified a gene mutation that causes a hereditary skeletal muscle disorder. The study is published in the "American Journal of Human Genetics".